Immune reaction after perforating keratoplasty. II. Prevention and therapy;Immunreaktion nach perforierender keratoplastik. II Pravention und therapie

Ophthalmologe

Volumn 95, Issue 6, 1998, Pages 444-459

  Pleyer, Uwe ^a   Rieck, Peter ^a   Ritter, Thomas ^a   Hartmann, Christian ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HLA SYSTEM; HLA TYPING; HUMAN; IMMUNITY; PENETRATING KERATOPLASTY; REVIEW;

CLINICAL TRIALS; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KERATOPLASTY, PENETRATING;

EID: 0031823675     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003470050296     Document Type: Review

References (85)

1. Alldredge OC, Krachmer JH (1981) Clinical types of corneal transplant rejection.Their manifestations, frequency, preoperative correlates and treatment. Arch Ophthalmol 99: 599-604
2. Ayliffe W, McLeoad D, Hutchinson IV (1992) Tolerance to rat corneal allografts induced by anti-CD4 antibodies. Invest Ophthalmol Vis Sci 33:831
3. Bach JF, Fracchia GN, Chatenoud L (1993) Safety and efficacy of therapeutic monoclonal antibodies in clinical trials. Immunol Today 14: 421-425
4. Baggesen K, Ehlers N, Lamm LU (1991) HLA-DR/RFLP compatible corneal grafts. Acta Ophthalmol 69:229-233
5. Batchelor JR, Casey TA, Gibbs DC (1976) HLA-matching and corneal grafting. Lancet 1 551-554
6. Beato M (1989) Gene regulation by steroid hormones. Cell 56:335-344
7. Beekhuis Wh, van Rij G, Renardel de Lavalette JGC, Rinkel-van Driel E, Persijn G, d'Amaro J (1991) Corneal graft survival in HLA-A and HLA-B matched transplantations in high-risk cases with retrospective review of HLA-DR compatibility. Cornea 10:9-12
8. Belin MW, Bouchard CS, Frantz S, Chielinska J (1989) Topical cyclosporine in high risk corneal transplantats. Ophthalmology 96:1144-1150
9. Belin MW, Bouchard CS, Philips TM (1990) Update on topical Cyclosporin A. Background, immunology and pharmacology. Cornea 9:184-195
10. Bell TAG, Easty DL, McCullagh KG (1982) A placebo-controlled blind trial of cyclosporin-A in prevention of corneal graft reaction in rabbits. Br J Ophthalmol 66:303-308
11. Böhnke M, Vogelberg K (1987) HLA-Antigene und Keratoplastik. Fortschr Ophthalmol 84: 519-528
12. Boisjoly HM, Roy R, Dubé I, Laughrea PA, Michaud R, Douville P, Herbert J (1986) HLA-A,-B, and-DR-matching in corneal transplanta-tion. Ophthalmology 93:1290-1295
13. Boisjoly HM, Roy R, Bernard P-M, Dubé I, Laughrea PA, Bazin R (1990) Association between corneal allograft reactions and HLA compatibility. Ophthalmology 97:1689-1696
14. Borel JF (1989) Pharmacology of cyclosporine (Sandimmune). Pharmacol Rev 41
15. Bradley BA, Vail A, Gore SM et al. on behalf of the Corneal Transplantat Follow-up Study Collaborators (1994) Negative effect of HLA-DR matching on corneal transplant rejection. Transplant Proc 27:1392-1398
16. Buxton JN, Apisson JG, Hoeffle FB (1969) Corticosteroids in 100 keratoplasties. Am J Oph-thalmol 67:46-51
17. CCTS:The collaborative corneal transplantation studies (1992) Effectiveness of histocompatibility matching in high-risk corneal transplantation. Arch Ophthalmol 110:1392-1403
18. Coster DJ (1989) Mechanisms of corneal graft failure:the erosion of corneal privilege. Eye 2:251-262
19. Donish PC, Cavanagh D, Boruchoff SA, Dohlman CH (1981) Posterior subcapsular cataract induced by topical corticosteroids following keratoplasty for keratoconus. Ann Ophthalmol 13: 12-15
20. Foets B, Missotten L, Vanderveren P, Goossens W (1985) Prolonged survival of allogenic corneal grafts in rabbits treated with topically applied cyclosporin A:systemic absorption and local immunosuppressive effect. Br J Ophthalmol 69:600-603
21. Foster CS, Wu HK, Merchant A (1993) Systemic (serum) soluble interleukin-2 receptor levels in corneal transplant recipients. Doc Ophthalmol 83:83-90
22. Foulks GN, Sanfllippo FP, Locascio JA 3 d, MacQueen JM, Dawson DV (1983) Histocompatibility testing for keratoplasty in high-risk patients. Ophthalmology 90:239-244
23. Gibbs DC, Batchelor JR, Werb A, Schlesinger W, Casey TA (1974) The influence of tissue-type compatibility on the fate of full-thickness corneal grafts. Trans Ophthalmol Soc UK 94:101-126
24. Gore SM, Vail A, Bradley BA, Rogers CA, Easty DL, Armitage WJ On behalf of the Corneal Transplant Follow-up Study Collaborators (1995) HLA-DR matching in corneal transplantation. Systemic review of published evidence. Transplantation 60:1033-1039
25. Harrison RN, Lippman SS (1989) How steroid hormones work. Hosp Prac 24:63-76
26. He YG, Ross J, Niederkorn JK (1991) Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody. Invest Ophthalmol Vis Sci 32: 2723-2728
27. He YG, Mellon J, Apte R, Niederkorn JK (1994) Effect of LFA-1 and ICAM-1 antibody treatment on murine cornea allograft survival. Invest Ophthalmol Vis Sci 35:3218-3225
28. He YG, Mellon J, Niederkorn JK (1996) The effect of oral immunization on cornea allograft survival. Transplantation 61:920-926
29. Hess AD, Esa AH, Colombani PM (1988) Mechanism of action of cyclosporine. Effects on cells of the immune system and on subcellular eventsin T-cell activation. Transplant Proc 20: 29-40
30. Hoffmann F, Keyserlingk HJ von, Wiederholt M (1986) Die Bedeutung der HLA-Typisierung bei Hornhauttransplantaten mit ungünstiger Prognose unter Cyclosporin-Therapie. Fortschr Ophthalmol 83:542-546
31. Hoffmann F, Kruse HA, Meinhold H, Bechrakis NE, Heimann H, Diamantstein T (1994) Interieukin-2 receptor-targeted therapy by monoclonal antibodies in the rat corneal graft. Cornea 13: 440-446
32. Hoffmann F (1994) Topical Cyclosporin A in corneal transplantation. In: Zierhut M, Pleyer U, Thiel HJ (eds) Immunology of corneal transplantation. Aeolus, Buren, pp 253-262
33. Holbach LM, Bayer J, Seitz B, Rummelt C, Naumann GOM (1993) Herpes simplex-Keratitis: zur Langzeitprognose von Ersttransplantaten nach perforierender Keratoplastik. Ophthalmologe 90:698-702
34. Hill JC (1989) The use of cyclosporine in high-risk keratoplasty. Am J Ophthalmol 107: 506-510
35. Hill C, Maske R, Watson P (1991) Corticosteroids in corneal graft rejection. Oral versus single pulse therapy. Ophthalmology 98:329-333
36. Hill C (1994) Systemic cyclosporine in high risk keratoplasty. Ophthalmology 101:128-133
37. Ippoliti G, Fronterrè A (1989) Usefulness of CD3 or CD6 anti-T monoclonal antibodies in the treatment of acute corneal graft rejection. Transplant Proc 21:3133-3134
38. Kana JS, Hoffmann F, Buchen R (1982) Rabbit corneal allograft survival following topical administration of cyclosporin A. Invest Ophthalmol Vis Sci 22:686-690
39. Kersten A, Sundmacher R, Reinhard T (1997) Postoperative Komplikationen nach perforierender Keratoplastik in Herpesaugen. Ophthalmologe 94:889-896
40. Küchle M, Nguyen NX, Amann T, Schumacher S, Naumann GOH (1996) Tyndallometrie zur Therapiekontrolle nach perforierender Keratoplastik und bei Transplantatreaktion. Spektrum Augenheilkd 10:47-52
41. Larkin DFP, Oral HB, Ring CJA, Lemoine NR, George AJT (1996) Adenovirus-mediated gene delivery to the corneal endothelium. Transplantation 61:363-370
42. Leibowitz HM, Kupferman A (1976) Kinetics of topically administered prednisolone acetate. Arch Ophthalmol 94:1387-1389
43. Leibowitz HM (1980) Management of inflammation in the cornea and conjunctiva. Ophthalmology 87:753-757
44. Mayer DJ, Casey TA (1987) Reducing the risk of coronal graft rejection. A comparison of different methods. Cornea 6:261-268
45. Meyes AL, Sugar A, Musch DC, Barnes RD (1994) Antiviral therapy after penetrating keratoplasty for herpes simplex keratitis. Arch Ophthalmol 112:601-607
46. Milani J, Pleyer U, Dukes A, Chou HJ, Lutz S, Rückert D, Schmidt KH, Mondino BJ (1993) Prolongation of corneal allograft survival with liposome-encapsulated cyclosporine in the rat eye. Ophthalmology 100:890-896
47. Miller K, Huber C, Niederwieser D, Göttinger W (1988) Successful engraftment of high-risk corneal allografts with short-term imm-unosuppression with cyclosporine.Transplantation 45:651-653
48. Mills RA, Jones DB, Winkler CR, Wallace GW, Wilhelmus KR (1995) Topical FK-506 prevents experimental corneal allograft rejection. Cornea 14: 157-160
49. Morris RE, Shorthouse R (1990) A study of the contrasting effects of cyclosporine, FK 506, and rapamycin on suppression of allograft rejection. Transplant Proc 22:1638-1641
50. Musch DC, Schwartz AE, Fitzgerald-Shelton K, Sugar A, Meyer RF (1991) The effect of allograft rejection after penetrating keratoplasty on central endothelial cell density. Am J Ophthalmol 111:739-742
51. Naumann GOH (1995) The Bowman Lecture. Eye 9:395-421
52. Newman DK, Isaacs JD, Watson PG, Meyer PA, Hale G, Waldmann H (1995) Prevention of immunemediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAM-PATH-1H. Eye 9:564-569
53. Nicholls SM, Bradley BB, Easty DL (1991) Effect of mismatches for major histocompatibility complex and minor antigens on corneal graft rejection. Invest Ophthalmol Vis Sci 32: 2729-2734
54. Niederkorn JY, Lang LS, Ross J, Mellon J, Robertson SM (1994) Promotion of corneal allograft survival with leflunomide. Invest Ophthalmol Vis Sci 35:3783-3785
55. Nishi M, Herbort CP, Matsubara M, Morishita Y, Nishimura M, Nieda M, Mori S, Mochizuki M (1993) Effects of the immunosuppressant FK 506 on a penetrating keratoplasty rejection model in the rat. Invest Ophthalmol Vis Sci 34:2477-2486
56. Nussenblatt RB, Palestine AG (1986) Cyclosporine: immunology, pharmacology and therapeutic uses. Surv Ophthalmol 31:159-169
57. Olsen TW, Benegas NM, Morali S, Mindrup EA, Holland EJ (1993) Low dose rapamycin and 15-deoxyspergualin significantly prolong allograft survival in the orthotopic rat keratoplasty model. Invest Ophthalmol Vis Sci 34:1365
58. Olsen TW, Benegas NM, Joplin AC, Evangelista T, Mindrup EA, Holland EJ (1994) Rapamycin inhibits corneal allograft rejection and neovascularization. Arch Ophthalmol 112:1471-1475
59. Pleyer U, Weidle EG, Thiel HJ (1989) The use of cyclosporine in high-risk keratoplasty. Am J Ophthalmol 108:467-468
60. Pleyer U, Ruckert D, Bachmann W, Schmidt KH, Thiel HJ (1991) Intraokulare Verfügbarkeit liposomenverkapselter monoklonater Antikörper im Kaninchenmodell. Ergebnisse einer Pilotstudie. Fortschr Ophthalmol 88:870-874
61. Pleyer U, Steuhl KP, Weidle EG, Lisch W, Thiel H-J (1992) Corneal graft rejection: incidence, manifestation, and interaction of clinical subtypes. Transplant Proc 24:2034-2037
62. Pleyer U, Lutz S, Jusko WJ, Nguyen K, Narawane M, Ruckert D, Mondino BJ, Lee VHL (1993) Ocular absorption of topically applied FK 506 from liposomal and oil formulations in the rabbit eye. Invest Ophthalmol Vis Sci 34:2737-2742
63. Pleyer U, Raphael B, Kosmidis P, Ryffel B, Thiel HJ (1993) Verteilung von Cyclophilin in okulären Geweben. Ophthalmologe 90:118
64. Pleyer U, Zierhut M, Thiel HJ (1994) Antibodies as preventive/therapeutic agents in corneal graft rejection. In: Zierhut M, Pleyer U, Thiel HJ (eds) Immunology of corneal transplantation. Aeolus, Buren, pp 263-275
65. Pleyer U, Elkins B, Rückert D, Lutz S, Grammer J, Chou J, Schmidt KH, Mondino BJ (1994) Ocular absorption of cyclosporine A from liposomes incorporated into collagen shields. Curr Eye Res 13:177-181
66. Pleyer U, Milani JH, Dukes A, Chou J, Mondino BJ (1995) Effect of liposome encapsulated anti-CD4 monoclonal antibodies on orthotopic corneal allografts in a rat model. Invest Ophthalmol Vis Sci 35:52-61
67. Pleyer U, Milani JK, Ruckert D, Rieck P, Mondino BJ (1997) Determinations of serum tumor necrosis factor alpha in corneal allografts. Ocular Immunol Inflamm 5:149-155
68. Pleyer U, Druegg A, Bertelmann E, Roth D, Rieck P, Reszka R, Hartmann C (1997) Liposome mediated gene transfer into corneal endothelial cells. Invest Ophthalmol Vis Sci 38:402
69. Pleyer U (1997) Immunreaktion nach perforierender Keratoplastik. Immunbiologie, Prävention und Therapie. Ophthalmologe 94:933-950
70. Pleyer U, Hartmann C, Rieck P, Kolls J, Volk HD, Ritter T (1998) Adenovirus-mediated gene transfer of IL-4 to rat cornea leads to high expression of rat IL-4 in vitro. Invest Ophthalmol Vis Sci 39:1119
71. Rinne JR, Stulting RD (1992) Current practice in the prevention and treatment of corneal allograft rejection. Cornea 11:326-328
72. Sanfilippo FP, MacQueen JM, Vaughn WK, Foulks GN (1986) Reduced graft rejection with good HLA-A and -B matching in high risk corneal transplantation. N Engl J Med 315:29-35
73. Severin M (1994) Perforierende Keratoplastik. Differentialdiagnose und Therapie postoperativer Komplikationen. Springer, Berlin Heidelberg New York, S 169-177
74. Shapiro R, Fung JJ, Jain A, Parks P, Todo S, Starzl TE (1990) The side effects of FK 506 in humans. Transplant Proc 22:41-43
75. Sigal NH, Dumont FJ (1992) Cyclosporin A, FK 506 and rapamycin: pharmacologic probes of lymphocyte signal transduction. Ann Rev Immunol 10:519-560
76. Sonkin PL, Baratz KH, Fronthingham R, Cobo LM (1992) Acyclovir resistant herpes simplex virus keratouveitis after penetrating keratoplasty. Ophthalmology 99:1805-1808
77. Sugar A, Bokosky JE, Meyer RF (1993) A randomized trial of topical corticosteroids in epithelial healing after keratoplasty. Cornea 3:268-271
78. Sundmacher R, Reinhard T, Heering P (1992) Six years experience with systemic Cyclosporin A prophylaxis in high risk perforating keratoplasty patients. German J Ophthalmol 1: 432-436
79. Sundmacher R, Reinhard T (1994) Cyclosporin A in high risk perforating keratoplasty. In: Zierhut M, Pleyer U, Thiel HJ (eds) Immunology of corneal transplantation. Aeolus, Amsterdam, pp 233-238
80. Takahashi N, Hayano T, Suzuki M (1989) Peptidylpropyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature 337:473
81. Thompson P, Xu D, Chen H, Brunette I (1993) Effect of rapamycin and cyclosporin on corneal rejection in the rat penetrating keratoplasty model. Invest Ophthalmol Vis Sci 34:1101
82. Völker-Dieben HJ, Kok-van Alphen CC, Landsbergen Q, Persijn GG (1982) Advances and disappointments, indications and restrictions regarding HLA-matched corneal grafts in high risk cases. Doc Ophthalmol 46:219-226
83. Waldmann H (1989) Manipulation of T-cell responses with monoclonal antibodies. Annu Rev Immunol 7:407-444
84. Weekers JF, Malaise-Stals J (1983) Etude à long terme de la densité cellulaire endothéliale après keratoplastie perforante. J Fr Ophthalmol 12:951-958
85. Zhang EP, Pleyer U, Hoffmann F, Hartmann C (1996) Effect of thalidomide on experimental keratoplasty. Invest Ophthalmol Vis Sci 37:867